SecBot SecBot
Insider Buy ·Filed Jul 28, 2026

MPLT

MapLight Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001696923-26-000007
Insider cluster: 1 insiders, $149K total
Actionable Insight • Neutral

The $149K director buy is too small relative to market cap to be a meaningful signal. The 9 insider sales totaling $1.7M in the same 30-day window are more notable by dollar volume, though many may be liquidity-driven. Monitor for any C-suite buying or a larger director purchase to confirm conviction.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
MPLT ▼ -45.07% at T+60d
NEUTRAL call -45.07% · α vs SPY -49.80% · entry $15.02 → $8.25
Entry = T+0 close
Jul 28, 2026
via day close
T+1d
-6.59%
call -6.59% · α -8.27%
$14.03
settled 3mo ago
T+5d
-13.98%
call -13.98% · α -19.51%
$12.92
settled 3mo ago
T+20d
-14.38%
call -14.38% · α -19.40%
$12.86
settled 2mo ago
T+60d
-45.07%
call -45.07% · α -49.80%
$8.25
settled 6d ago

Price Chart

Loading chart...

Executive Summary

Director Troy Cox made a single open-market purchase of 15,620 MPLT shares for ~$149K at $9.52, representing 0.03% of the company's $449M market cap. While a lone insider buy is a recognized bullish signal per academic literature, the dollar amount is trivial relative to market cap and the buyer is a director, not C-suite. The purchase is too small to carry material conviction weight on its own.

Key Financial Metrics

Direction
buying
Total Value
$148.7K
Insiders
1

Key Facts

  • Director Troy Cox purchased 15,620 shares at $9.52 for a total of $148,702 on 2026-07-28
  • Purchase represents ~0.03% of MPLT's $449M market cap
  • This is the only insider buy in the last 30 days, compared to 9 insider sales totaling $1.7M over the same period
  • Analyst consensus is 94% bullish (6 Strong Buy, 11 Buy, 1 Hold)

Financial Impact

Insider purchase of $149K is trivial at 0.03% of market cap

insider ownership

Risk Factors

  • Insider purchase is trivial relative to market cap at 0.03%
  • 9 insider sales totaling $1.7M in the same 30-day period outweigh the single buy by dollar volume
  • Director-level buy carries less signal weight than a C-suite purchase

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001696923-26-000007
31 reports for MPLT
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 6 of 7 best @ T+60▲ +57.24%May 18, 2026
Filters
Rows
Reports for MPLT — sortable, filterable
TypeNow
Oct 16, 2026
11d ago
Insider Cluster
BEARISH ★ 4/10
$8.00awaiting T+20—$8.17 (−2.13%)
Oct 15, 2026
12d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$8.17 (+6.10%)
Oct 15, 2026
12d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$8.17 (+6.10%)
Oct 15, 2026
12d ago
144
NEUTRAL ★ 2/10
$7.70awaiting T+20—$8.17 (+6.10%)
Sep 24, 2026
4w ago
EFFECT
NEUTRAL ★ 4/10
$10.76 $8.25▼ −23.33%▼ −22.91%$8.17 (−24.07%)
Sep 18, 2026
5w ago
S-1/A
NEUTRAL ★ 4/10
$10.90 $8.00▼ −26.61%▼ −25.70%$8.17 (−25.05%)
Aug 4, 2026
11w ago
Insider Cluster
BULLISH ★ 7/10
$12.92 $13.06▲ +1.08%▲ +1.69%$8.17 (−36.76%)
Aug 3, 2026
12w ago
144
NEUTRAL ★ 2/10
$12.94 $13.31▲ +2.86%▲ +4.10%$8.17 (−36.86%)
Jul 30, 2026
12w ago
144
BEARISH ★ 5/10
$13.02 $12.60▲ +3.23%▲ +6.21%$8.17 (+37.25%)
Jul 28, 2026
12w ago
Insider Buy
NEUTRAL ★ 3/10
$15.02 $12.86▼ −14.38%▼ −19.40%$8.17 (−45.61%)
Showing 10 of 31

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 28, 2026